INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS)

Historical Holders from Q2 2023 to Q3 2025

Type / Class
Equity / Common Stock, $0.0001 par value
Symbol
INTS on Nasdaq
Shares outstanding
48,324,727
Price per share
$0.59
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
2,961,433
Total reported value
$721,188
% of total 13F portfolios
0%
Share change
+982,735
Value change
+$231,320
Number of holders
26
Price from insider filings
$0.59
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
ARMISTICE CAPITAL, LLC 2.6% -53% $383,505 +$113,015 1,237,113 +42% Armistice Capital, LLC 30 Jun 2025
SAPIENT CAPITAL LLC 3.9% -50% $312,575 -$11,287 976,797 -3.5% SAPIENT CAPITAL LLC 30 Jun 2025
As of 30 Sep 2025, INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) has 26 institutional shareholders filing 13F forms. They hold 2,961,433 shares. of 48,324,727 outstanding shares (6.1%) .

Institutional Holders of INTENSITY THERAPEUTICS, INC. - Common Stock, $0.0001 par value (INTS) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 2,961,433 $721,188 +$231,320 $0.24 26
2025 Q2 1,978,698 $606,612 -$1,718,334 $0.31 27
2025 Q1 2,588,459 $5,099,279 -$255,643 $1.97 21
2024 Q4 2,720,161 $4,790,715 +$1,642,568 $1.76 20
2024 Q3 1,740,070 $6,647,274 +$185,658 $3.82 20
2024 Q2 1,678,720 $8,230,325 +$224,021 $4.90 22
2024 Q1 1,632,608 $8,490,357 +$5,402,744 $5.20 17
2023 Q4 512,614 $4,392,713 +$236,954 $8.57 16
2023 Q3 298,447 $1,190,347 +$1,020,510 $3.97 10
2023 Q2 28,563 $170,235 +$170,235 $5.96 2